Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(75%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Detailed Status

Recruiting3

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting375%

completed125%

Recent Activity

3 active trials

Showing 4 of 4

recruitingnot_applicable

Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord Injury

NCT07739992

completednot_applicable

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

NCT06520358

recruitingnot_applicable

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

NCT07002437

recruitingnot_applicable

BioFLO for Respiratory Recovery in SCI

NCT06011876

Clinical Trials (4)

Showing 4 of 4 trials

NCT07739992Not Applicable

Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord Injury

Recruiting

NCT06520358Not Applicable

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

Completed

NCT07002437Not Applicable

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

Recruiting

NCT06011876Not Applicable

BioFLO for Respiratory Recovery in SCI

Recruiting

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4